Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.84
-0.06 (-0.87%)
Jun 3, 2026, 11:27 AM EDT - Market open
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $754.45 million as of June 3, 2026. Its market cap has increased by 189.74% in one year.
Market Cap
754.45M
Enterprise Value
663.32M
1-Year Change
189.74%
Ranking
Category
Stock Price
$6.84
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $754.45M, an increase of 89.69%. That is a compound annual growth rate of 14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 793.05M | 129.14% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kura Oncology | 796.31M |
| ORIC Pharmaceuticals | 788.80M |
| LB Pharmaceuticals | 774.84M |
| Phathom Pharmaceuticals | 766.50M |
| Bright Minds Biosciences | 757.92M |
| Geron | 750.58M |
| Omeros | 742.57M |
| Oculis Holding AG | 742.17M |